Avalo Therapeutics, Inc. - AVTX

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 9/9/2026 10:01:45 PM
EDGAR CIK 0001534120

Buy Breakdown

Total $0

Sell Breakdown

Total $617,656

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
08/11/2026
08/12/2026
Riley Jennifer
Chief Strategy Officer
Officer
Sell
-2,655 @ $19.59
($52,012.25)
 37,041 (-6.69%) Direct
05/06/2026
10b5-1
05/07/2026
Chan Mitchell
Director
Sell
-3,167 @ $22.88
($72,460.96)
 3,166 (-50.01%) Direct
04/30/2026
10b5-1
05/01/2026
Sullivan Christopher Ryan
Chief Financial Officer
CFO
Sell
-8,457 @ $13.23
($111,853.13)
 423 (-95.24%) Direct
04/29/2026
10b5-1
05/01/2026
Sullivan Christopher Ryan
Chief Financial Officer
CFO
Sell
-8,458 @ $13.09
($110,736.36)
 8,880 (-48.78%) Direct
04/02/2026
10b5-1
04/03/2026
Sullivan Christopher Ryan
Chief Financial Officer
CFO
Sell
-7,980 @ $17.15
($136,823.11)
 17,338 (-31.52%) Direct
04/01/2026
10b5-1
04/03/2026
Sullivan Christopher Ryan
Chief Financial Officer
CFO
Sell
-7,979 @ $16.77
($133,769.91)
 25,318 (-23.96%) Direct